CIK 0001745999
- Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −7,157 | $32.13 | $230K | 86,590 |
| 2024-04-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −3,401 | $32.12 | $109K | 104,594 |
| 2024-04-01 | Burrell Terry-Ann Chief Financial Officer | Sale 10b5-1 | −5,446 | $32.12 | $175K | 70,137 |
| 2024-04-01 | Evans John M. CEO | Sale 10b5-1 | −18,102 | $32.13 | $582K | 1,058,343 |
| 2024-04-01 | Ciaramella Giuseppe President | Sale 10b5-1 | −4,534 | $32.12 | $146K | 169,616 |
| 2024-03-28 | Evans John M. CEO | Sale 10b5-1 | −60,000 | $33.86 | $2.0M | 998,262 |
| 2024-02-14 | FMR LLC | Sale | −854,323 | $30.51 | $26.1M | 1,281,188 |
| 2024-02-14 | FMR LLC | Sale | −45,677 | $31.34 | $1.4M | 1,235,511 |
| 2024-02-13 | FMR LLC | Sale | −410 | $30.28 | $12K | 2,773,068 |
| 2024-02-13 | FMR LLC | Sale | −1,155 | $30.93 | $36K | 2,771,913 |
| 2024-01-31 | Evans John M. CEO | Sale 10b5-1 | −60,000 | $25.33 | $1.5M | 1,058,262 |
| 2024-01-03 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −1,907 | $26.42 | $50K | 80,495 |
| 2023-11-20 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −5,000 | $30.00 | $150K | 87,402 |
| 2023-11-20 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −5,000 | $31.00 | $155K | 82,402 |
| 2023-10-30 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −3,448 | $18.70 | $64K | 65,469 |
| 2023-10-02 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −388 | $22.85 | $9K | 82,402 |
| 2023-07-24 | Ciaramella Giuseppe President and CSO | Sale 10b5-1 | −1,206 | $32.01 | $39K | 48,250 |
| 2023-07-21 | Ciaramella Giuseppe President and CSO | Sale 10b5-1 | −155,324 | $32.06 | $5.0M | 48,250 |
| 2023-07-10 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −391 | $30.48 | $12K | 68,917 |
| 2023-04-04 | Evans John M. CEO | Sale 10b5-1 | −6,493 | $29.09 | $189K | 1,117,979 |
Page 4 of 13 · 249 trades